Mirum Pharmaceuticals Ownership | Who Owns Mirum Pharmaceuticals?
Mirum Pharmaceuticals Ownership Summary
Mirum Pharmaceuticals is owned by 77.50% institutional investors, 1.71% insiders, and 20.79% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 13.66% of MIRM shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.05% of its assets in Mirum Pharmaceuticals shares.
MIRM Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Mirum Pharmaceuticals | 77.50% | 1.71% | 20.79% |
| Sector | Healthcare Stocks | 232.86% | 10.65% | -143.51% |
| Industry | Biotech Stocks | 382.13% | 10.41% | -292.54% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Frazier life sciences management | 6.80M | 13.66% | $498.15M |
| Janus henderson group | 4.58M | 9.59% | $189.48M |
| Blackrock | 3.24M | 6.90% | $110.71M |
| Blackrock funding, inc. /de | 3.65M | 6.27% | $287.94M |
| Eventide asset management | 2.52M | 5.07% | $184.92M |
| Vanguard group | 2.60M | 4.47% | $205.07M |
| Bvf inc/il | 1.50M | 3.01% | $109.62M |
| State street | 1.35M | 2.71% | $98.74M |
| Price t rowe associates inc /md/ | 1.28M | 2.58% | $94.08M |
| Novo | 1.26M | 2.54% | $92.67M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Frazier life sciences management | 6.80M | 14.93% | $498.15M |
| Boone capital management | 535.73K | 12.88% | $39.27M |
| First turn management | 570.57K | 6.28% | $41.83M |
| Novo | 1.26M | 5.97% | $92.67M |
| Patient square capital lp | 298.68K | 5.05% | $23.59M |
| Highlander partners | 122.98K | 4.45% | $11.36M |
| Bvf inc/il | 1.50M | 4.44% | $109.62M |
| Tang capital management | 1.24M | 3.49% | $90.61M |
| Rock springs capital management lp | 761.13K | 3.26% | $55.80M |
| Eventide asset management | 2.52M | 3.04% | $184.92M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 3.24M | 0.00% | 785.78K |
| Wellington management group llp | 790.69K | 0.01% | 672.12K |
| Fmr | 640.22K | 0.00% | 580.78K |
| Arrowstreet capital, limited partnership | 612.32K | 0.03% | 536.67K |
| Point72 asset management | 790.67K | 0.10% | 531.81K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bvf inc/il | 1.50M | 4.44% | -1.27M |
| Bioimpact capital | - | - | -589.58K |
| Cadian capital management, lp | - | - | -475.71K |
| Macquarie group | - | - | -393.21K |
| Checkpoint capital | - | - | -362.19K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vanguard fiduciary trust | 333.33K | 0.01% | 333.33K | $30.79M |
| Norges bank | 263.18K | 0.00% | 263.18K | $20.79M |
| Axa investment managers | 255.69K | 0.05% | 255.69K | $18.74M |
| D. e. shaw | 157.35K | 0.00% | 157.35K | $6.51M |
| Voleon capital management lp | 86.53K | 0.15% | 86.53K | $6.34M |
Sold Out
| Holder | Change |
|---|---|
| Coldstream capital management | -1.00 |
| Tortoise investment management | -2.00 |
| Concord wealth partners | -5.00 |
| Nelson, van denburg & campbell wealth management group | -5.00 |
| Northwestern mutual wealth management | -9.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 219 | -21.22% | 45,026,857 | -21.48% | 77 | 0.80% | 124 | -24.39% | 63 | -18.18% |
| Sep 30, 2025 | 99 | -54.59% | 7,010,413 | -87.34% | 14 | 0.11% | 58 | -48.21% | 28 | -64.10% |
| Jun 30, 2025 | 216 | 0.47% | 55,383,162 | 4.20% | 111 | 0.94% | 110 | -9.84% | 78 | 23.81% |
| Mar 31, 2025 | 215 | 4.37% | 54,155,788 | 2.17% | 110 | 0.90% | 121 | 5.22% | 65 | 6.56% |
| Dec 31, 2024 | 194 | 5.43% | 43,660,980 | -17.71% | 91 | 0.74% | 109 | -3.54% | 56 | 40.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.83M | 3.05% | 454.01K |
| Vanguard US Total Market Shares ETF | 1.41M | 2.87% | 1.77K |
| Eventide Gilead N | 1.31M | 2.17% | -121.21K |
| State Street® SPDR® S&P® Biotech ETF | 1.03M | 1.69% | -10.18K |
| iShares Russell 2000 ETF | 991.01K | 1.63% | 8.37K |
| MEDICAL BioHealth EUR Acc | 756.50K | 1.59% | - |
| Janus Henderson US SMID Cap Growth MA | 679.10K | 1.37% | 679.10K |
| Janus Henderson Global Life Sciences D | 805.92K | 1.34% | 123.22K |
| Janus Henderson Global Life Sciences | 808.98K | 1.33% | 126.29K |
| Janus Henderson Triton D | 778.95K | 1.29% | -19.12K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 15, 2026 | Ramasastry Saira | - | Sell | $193.80K |
| Mar 16, 2026 | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | Sell | $670.24K |
| Mar 16, 2026 | Quan Joanne | CHIEF MEDICAL OFFICER | Sell | $670.24K |
| Mar 16, 2026 | Ramasastry Saira | - | Sell | $181.52K |
| Mar 16, 2026 | Radovich Peter | PRESIDENT AND COO | Sell | $1.52M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 1 |
| 2026 Q1 | 1 | 21 |
| 2025 Q4 | - | 6 |
| 2025 Q3 | - | 10 |
| 2025 Q2 | - | 3 |
MIRM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools